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DObjectives:We sought to critically analyze the routine use of conventional coronary angiography (CCA) before
noncoronary cardiac surgery and to assess clinical predictionmodels that might allowmore selective use of CCA
in this setting.
Methods:We studied 5463 patients undergoing aortic valve surgery, mitral valve surgery, or septal myectomy
with or without coronary artery bypass grafting from 2001 to 2010. Preoperative CCAs were evaluated for the
presence of significant coronary artery disease (CAD). Random forests and logistic regression methods were
used to determine the predictors of significant (50%) coronary stenosis.
Results: Preoperative CCAwas performed in 4711 patients (86%). Two thirds of those with angina, previous
myocardial infarction, or percutaneous coronary intervention had significant CAD found on CCA, versus one
third of patients free of these risk factors (P<.001). Among 3019 patients without angina, previous myocardial
infarction or percutaneous coronary intervention, older age, male gender, diabetes, and peripheral vascular
disease independently predicted significant CAD (P<.001 for all; C-index¼ 0.74). Specifically, a multivariate
model with these variables identified 10% (301 of 3019) of patients as having a low (10%) probability
of coronary stenosis, of whom fewer than 5% had significant CAD and fewer than 1% had left main or
triple-vessel coronary disease.
Conclusions: In the absence of angina, previous myocardial infarction, or percutaneous coronary intervention,
preoperative CCA identified significant CAD in only one third of patients. Our clinical prediction models could
enhance the identification of patients at low risk of significant CAD for whom CCAmight potentially be avoided
before cardiac surgery. This strategymay improve the efficiency of cardiac surgical care delivery by diminishing
procedure-relatedmorbidity and offering significant cost savings. (J Thorac Cardiovasc Surg 2013;146:1055-64)Supplemental material is available online.e Division of Cardiovascular Surgery,a Department of Biomedical Statistics
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In patients presenting for noncoronary cardiac surgery, un-
derlying coronary obstruction, if severe and not bypassed,
can confer deleterious effects on perioperative1 and long-
term outcomes.2 Thus, the identification of coexistent coro-
nary artery disease (CAD) using conventional coronary
angiography (CCA) has long been paramount in the assess-
ment of cardiac surgical candidates.3 However, owing to the
broad guidelines outlining which patients undergoing car-
diac surgery warrant angiography,4 the practice of screening
CCA has become ubiquitous. Although highly sensitive in
identifying patients with CAD, it has been proposed that
guideline specificity might be as low as 1% to 3%.5,6
When considered alongside recent trials demonstrating no
advantage for revascularization compared with medical
therapy in reducing the risk of myocardial infarction (MI)
or death—except in those with the most extensive
coronary disease7,8—the suggestion has been that adiovascular Surgery c Volume 146, Number 5 1055
Abbreviations and Acronyms
AVS ¼ aortic valve surgery
CAD ¼ coronary artery disease
CCA ¼ conventional coronary angiography
CABG ¼ coronary artery bypass grafting
MI ¼ myocardial infarction
MVS ¼ mitral valve surgery
OR ¼ odds ratio
PCI ¼ percutaneous coronary intervention
PVD ¼ peripheral vascular disease
SM ¼ septal myectomy
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Ddisproportionate number of patients coming to cardiac
surgery might be unnecessarily subjected to an invasive
and costly procedure.
Although the incidence of significant, but asymptomatic,
CAD in the general population remains unclear, a recent
report from the National Cardiovascular Data Registry
detailed that only one third of approximately 400,000
patients undergoing elective CCA were found to have
significant CAD.9 However, patients undergoing valvular
heart surgery—in whom coronary disease burden may be
increased10—were excluded from their analysis. Conse-
quently, the true diagnostic yield of preoperative CCA in
patients presenting for noncoronary cardiac surgery
remains unclear, and the need persists for an updated risk
stratification tool, allowing clinicians to consistently
assess the probability of concomitant CAD. We therefore
performed a large-scale retrospective study of patients
undergoing noncoronary cardiac surgery, with the aims of
(1) delineating the burden of underlying obstructive CAD,
and (2) developing simple bedside models to predict the
likelihood of significant coexistent coronary stenosis.METHODS
Study Design and Population
We performed an analysis of patients aged 18 years or older who had
undergone aortic valve surgery (AVS), mitral valve surgery (MVS), or
septal myectomy (SM), with or without concomitant coronary artery
bypass grafting (CABG), from 2001 to 2010. The exclusion criteria were
previous sternotomy, concomitant major procedures other than CABG
(eg, thoracic, aortic, or tricuspid valve surgery), active endocarditis, and
ischemic valve disease. The Mayo Clinic institutional review board
approved the present investigation.
Subjects were identified from the Division of Cardiovascular Surgery’s
patient database. A total of 10,677 consecutive patients had undergone
AVS, MVS, and/or SM at the Mayo Clinic (Rochester, Minn) from January
1, 2001 to December 31, 2010, of whom 5463 met the enrollment criteria
(Figure 1). The patients were divided into 2 groups according to the use of
CCAwithin 6 months of surgery (n ¼ 4711 CCA vs n ¼ 752 no CCA).
We further categorized the patients undergoing CCA into (1) those with
baseline angina symptoms, previousMI, or previous percutaneous coronary
intervention (PCI) (n¼ 1692) and (2) those patients free of these risk factors
(n ¼ 3019). The latter cohort was used to derive models predicting the1056 The Journal of Thoracic and Cardiovascular Surlikelihood of significant CAD at cardiac surgery. In an effort to maximize
the predictive accuracy, we constructed separate models for patients who
had undergone AVS (n ¼ 1668), MVS (n ¼ 1070), or SM (n ¼ 281).
Patients undergoing multiple procedures were analyzed in 1 category only
according to a priori rules. First, given the similarity in risk factors and/or
pathophysiologic mechanisms underlying the development of CAD and
aortic valve disease,11-13 patients undergoing AVS were analyzed in this
category, irrespective of concomitant procedures. Second, patients
undergoing combined MVS plus SM were analyzed according to the
primary surgical indication, as documented by the treating physician.
Clinical Data
The Division of Cardiovascular Surgery’s database and the medical
records were reviewed for patient demographics, medical history, baseline
symptoms, and perioperative outcomes. The variables evaluated when
constructing the prediction models included age, gender, diabetes mellitus,
peripheral vascular disease (PVD), hypertension, hypercholesterolemia,
smoking history, family history of CAD, cerebrovascular accident, New
York Heart Association functional class III-IV, impaired ejection fraction
(<50%), and obesity (body mass index 30 kg/m2). These variables
were defined in keeping with the standard criteria set forth by the Society
of Thoracic Surgeons as a part of the National Adult Cardiac Surgery
Database.14
The primary endpoint was significant CAD, defined as angiographic
evidence of 50% or more luminal stenosis of any of the epicardial coronary
vessels, including side branches.15 The secondary endpoints were high-risk
coronary disease, defined as 50% ormore stenosis of the left main coronary
artery or all 3 major epicardial vessels, and the need for CABG at baseline
surgery.
Coronary Angiograms
The results of the CCAs performed within 6 months of surgery were
available from the Division of Cardiovascular Disease Coronary Catheter-
ization database and by review of the medical records from our institution
and outside centers. CAD burden was assessed by the percentage of
luminal stenosis of coronary vessels as documented at the time of study.Statistical Analysis
Categorical variables are summarized as counts and percentages and
were compared between groups using the chi-square test. Continuous
variables were compared using t tests or the Wilcoxon rank-sum test, as
appropriate.
Univariate logistic regression models identified the risk factors for
CAD. A multivariate model for the overall cohort was constructed using
random forests for variable selection, and odds ratios were estimated by
entering these variables into logistic regression models. Random forests
are a nonparametric ensemble partitioning classification method that
calculates measures of prediction accuracy and variable importance.16
By resampling subjects and predictor variables, it can account for nonlinear
effects for variables and multi-way interactions between variables. The
contribution of each covariate to the overall prediction accuracy of CAD
was evaluated by measuring the changes in model accuracy when the factor
was not considered. A feature selection algorithm is preferable to stepwise
selection algorithms because the latter overestimate effect sizes and
underestimate standard errors.17 Variables identified using this method
according to prediction accuracy and variable importance were then
entered into multivariate logistic regression models to predict CAD.
To enhance utility by physicians at the bedside, multivariate models
limited to 4 main effects were selected according to the concordance index
in all subsets regression. Such models were constructed for the overall
cohort and separately for AVS, MVS, and SM subgroups. Internal
cross-validation with 200 bootstrap samples was used. The predicted
probabilities of CAD were calculated. After consultation with expertgery c November 2013
FIGURE 1. Identification of study subjects. CABG, Coronary artery
bypass grafting;CCA, conventional coronary angiography;MI, myocardial
infarction; PCI, percutaneous coronary intervention.
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Dcardiologists and cardiovascular surgeons, a low probability for significant
CAD was defined as 10% or less. This cutpoint has been used in multiple
cardiovascular studies18-21 and has previously been shown to be a valid
threshold for the classification of ‘‘low risk.’’22
The analyses were performed using Statistical Analysis Systems,
version 9.13, software (SAS Institute, Cary, NC), and the R package ran-
domForest, version 4.6-7, in the statistical software package,
R, version 2.15.3.23RESULTS
Baseline Clinical Characteristics
The baseline characteristics are listed in Table 1,
stratified by whether or not patients underwent preoperative
CCA within 6 months of surgery. Mean patient age was
65  15 years, and 3426 patients were men (63%).
Preoperative CCA was performed in 4711 patients (86%).
As expected, those who did not undergo CCAwere younger
and less symptomatic at index surgery. Coincident with
fewer baseline comorbidities, patients without preoperative
CCA also experienced fewer perioperative complications,
including lower operative mortality.CAD Burden
Of the 4711 patients with preoperative CCA, 2139 (45%)
had significant CAD, one third of whom (n ¼ 744) hadThe Journal of Thoracic and Carhigh-risk (see ‘‘Methods’’) CAD. Baseline CABG was
performed in only 1706 of the 4711 patients (36%)
evaluated by CCA.
Patients With Angina, Previous MI, and Previous
PCI
Patients with angina, previous MI, or previous PCI consti-
tuted36%of the population (1692of 4711) undergoingCCA.
In the presence of these established risk factors, the age- and
gender-adjusted odds of significant CAD was 4-fold greater
than in the absence of these 3 variables (odds ratio [OR],
3.94; 95% confidence interval, 3.44-4.53; P< .001). Two
thirds of the patients (1125 of 1692) with angina, previous
MI, or PCI had significant CAD on CCAversus one third of
patients (1014 of 3019) free of these risk factors. Baseline
CABG was thus performed in 958 of 1692 patients (57%)
with angina, previous MI, or PCI and in only 748 of 3019
of patients (25%) without these features on preoperative
history. Because of the preponderance of significant CAD
among the patients with these major risk factors, and given
our objective of identifying those with a low disease
probability, we focused on the 3019 patients without angina,
previous MI, or PCI when constructing prediction models.
CADPrediction Among All PatientsWithout Angina,
Previous MI, or PCI
The univariate predictors of significant CAD in the 3019
patients without angina or previous MI or PCI are outlined
in Table E1. Multivariate predictors of CAD included older
age, male gender, diabetes, PVD, family history of CAD,
hypertension, hypercholesterolemia, and smoking history
(C-index ¼ 0.76; Table E1).
The 4-variable model consisting of older age (OR, 1.4 per
5 years), male gender (OR, 1.9), diabetes (OR, 2.3), and
PVD (OR, 2.7) had the best discriminative power for
predicting CAD (P < .001 for all; C-index ¼ 0.74).
According to this model, 10% (301 of 3019) of the patients
in our study population had a 10% or less, or low, predicted
probability of CAD. Reassuringly, fewer than 5% (14 of
301) of these patients actually had angiographic evidence
of CAD, and only 1 patient—with left main coronary artery
stenosis—had high-risk CAD (Table 2).
Of the 552 patients with diabetes or PVD, 55% (304) had
significant CADcomparedwith 29% (710)whowere free of
both these risk factors. Specifically, the absence of diabetes
and PVD was associated with a 67% reduction in CAD risk
relative to the presence of 1 or both variables (OR, 0.33;
95% confidence interval, 0.27-0.4; P< .001). Moreover,
and in agreement with our 4-variable model, 99.5%
(549 of 552) of patients in our study populationwith diabetes
or PVD had a greater than 10% predicted probability of
CAD.
We thus sought to identify gender-specific age thresh-
olds associated with a 10% or less probability ofdiovascular Surgery c Volume 146, Number 5 1057
TABLE 1. Baseline and perioperative characteristics of total cohort stratified by CCA status
Variable Total (n ¼ 5463) No CCA (n ¼ 752) CCA (n ¼ 4711) P value*
Mean age (y) 65  15 47  16 68  13 <.001
Male gender 3426 (63) 429 (57) 2997 (64) <.001
NYHA class III-IV 3054 (56) 384 (51) 2670 (57) <.001
Angina 1555 (29) 182 (24) 1373 (29) .005
Congestive heart failure 787 (14) 54 (7) 733 (16) <.001
Cerebrovascular accident 213 (4) 11 (1) 202 (4) <.001
Diabetes mellitus 886 (16) 44 (6) 842 (18) <.001
Hypercholesterolemia 3879 (71) 395 (53) 3484 (74) <.001
Family history of CAD 546 (10) 70 (9) 476 (10) .5
Hypertension 3352 (61) 269 (36) 3083 (65) <.001
Previous MI 489 (9) 18 (2) 471 (10) <.001
Obese (BMI 30 kg/m2) 1928 (35) 271 (36) 1657 (35) .65
Peripheral vascular disease 362 (7) 16 (2) 346 (7) <.001
Smoker 2847 (52) 327 (43) 2520 (53) <.001
Previous PCI 500 (9) 23 (3) 477 (10) <.001
Ejection fraction<50% 664 (12) 38 (5) 626 (13) <.001
Surgical procedure <.001
Isolated aortic valve surgery 2585 (47) 169 (22) 2416 (51)
Isolated mitral valve surgery 1551 (28) 236 (31) 1315 (10)
Isolated septal myectomy 762 (14) 277 (37) 485 (10)
Combined procedure 565 (10) 70 (9) 495 (11)
Perioperative MI 11 (0.2) 1 (0.1) 10 (0.2) .65
Operative mortality 88 (2) 3 (0.4) 85 (2) .005
Hospital length of stayy (d) 6 (5-8) 5 (4-6) 6 (5-8) <.001
Data are presented as mean  standard deviation or n (%), unless otherwise noted. CCA, Conventional coronary angiography; NYHA, New York Heart Association;
CAD, coronary artery disease; MI, myocardial infarction; BMI, body mass index; BSA, body surface area; PCI, percutaneous coronary intervention. *P value represents the
comparison of patients with preoperative CCA versus those without CCA. yData presented as median (interquartile range).
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Dsignificant CAD to clarify which patients were at lowest
risk. Overall, men aged 44 years or younger and
women aged 52 years or younger had a low probability
(10%) of significant CAD. In the absence of diabetes
and PVD, the age threshold was 45 years or younger and
55 years or younger for men and women, respectivelyTABLE 2. Four-variable prediction models of significant CAD: overall an
Category (n) Variables OR (95% CI) P value Model C-index*
All patients (3019) Agey 1.4 (1.3-1.5) <.001 0.74
Male 1.9 (1.6-2.2) <.001
DM 2.3 (1.8-2.8) <.001
PVD 2.7 (1.9-4.0) <.001
AVS (1668) Agey 1.3 (1.2-1.3) <.001 0.69
Male 1.9 (1.5-2.4) <.001
DM 1.9 (1.5-2.4) <.001
PVD 2.3 (1.5-2.5) <.001
MVS (1070) Agey 1.5 (1.3-1.5) <.001 0.75
Male 1.6 (1.1-2.2) .006
DM 3.1 (1.8-5.3) <.001
PVD 3.9 (1.9-8.3) <.001
SM (281) Agey 1.3 (1.2-1.7) .001 0.70
Male 2.4 (1.03-5.9) .04
CAD, Coronary artery disease; OR, odds ratio; CI, confidence interval; LMA, left main
DM, diabetes mellitus; PVD, peripheral vascular disease; AVS, aortic valve surgery; MVS,
C-indexes were within 0.005 of the original value. yAge increase by 5-y increments.
1058 The Journal of Thoracic and Cardiovascular Sur(Figure 2, A). Of the 2467 patients free of diabetes
and PVD, 344 (14%) were younger than the age thresh-
olds consistent with a low probability of CAD at index
surgery. Significant disease was detected in 16 of these
344 patients (4.7%), only 1 of whom had high-risk
CAD.d by surgical procedure
Predicted low probability (10% probability of CAD)
n (%) Significant CAD (%) LMA/3VD (%) CABG (%)
301/3019 (10) 14/301 (4.7) 1/301 (0.3) 8/301 (3)
17/1668 (1) 1/17 (5.9) 0/17 (0) 0/17 (0)
254/1070 (24) 12/254 (4.7) 2/254 (0.7) 8/254 (3)
148/281 (53) 8/148 (5.4) 0/148 (0) 5/148 (3)
artery disease; 3VD, triple-vessel disease; CABG, coronary artery bypass grafting;
mitral valve surgery; SM, septal myectomy. *After bootstrap validation, all adjusted
gery c November 2013
FIGURE 2. Gender-specific age thresholds predicting low probability of coronary artery disease (CAD) in the absence of diabetes and peripheral vascular
disease (PVD). A, Age thresholds consistent with a 10% or less predicted probability of CAD in all men and women free of diabetes and PVD undergoing
noncoronary cardiac surgery. Gender-specific age thresholds are also depicted for subsets of patients undergoing (B), aortic valve surgery, (C), mitral valve
surgery, and (D), septal myectomy.
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We further sought to generate separate risk prediction
models and to establish age-threshold ‘‘rules’’ for the
subsets of patients who had undergone AVS, MVS, or SM.
AVS group. AVS was performed in 1668 of 3019 (55%)
patients, of whom 1465 (88%) had predominant aortic
valve stenosis. Of the 1668 patients, 1611 (97%) underwent
aortic valve replacement. Significant coronary stenosis was
present on CCA in 44% (726 of 1668) of patients, and
concomitant CABG was performed in 33% (549 of 1668)
of patients. The most predictive model for significant
CAD again included older age, male gender, diabetes, and
PVD (C-index ¼ 0.69; Table 2). The age cutoff consistent
with a low probability of significant CAD at AVS was 31
years or younger in men and 44 years or younger in women.
In the absence of diabetes and PVD, the age thresholdThe Journal of Thoracic and Carincreased slightly to 33 years or younger and 46 years or
younger in men and women, respectively (Figure 2, B).
MVS group. Of the 1070 patients who underwent MVS,
moderate or severe valve regurgitation was evident in
1035 (97%), and valve repair was performed in 905
(85%), including those with regurgitation, stenosis, and
leaflet tethering or calcification. CCA detected CAD in
one fourth (257 of 1070) of patients, and concomitant
CABG was performed in 17% (180 of 1070). In the MVS
population, older age, male gender, diabetes, and PVD
remained the most prominent predictors of CAD
(C-index ¼ 0.75; Table 2). Age 50 years or younger in
men and 54 years or younger in women predicted a 10%
or less probability of significant CAD. The age threshold
increased slightly to 51 and 57 years in men and women
free of diabetes and PVD, respectively (Figure 2, C).diovascular Surgery c Volume 146, Number 5 1059
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DSM group. Significant CAD was diagnosed in 31 of 281
(11%) of those in the SM cohort, and concomitant CABG
was performed in 19 (7%). Because of the small number
of events in the SM subset (n ¼ 31), the use of 4 variables
in a predictive model would have resulted in overfitting
and was hence inappropriate. Although the top 2 predictors
remained age and male gender, the addition of a third vari-
able contributed minimally to overall model discrimination.
Thus, among patients undergoing SM, we opted to fit a
2-variable model, with older age and male gender
(C-index ¼ 0.70; Table 2). Of all 281 patients undergoing
SM, a 10% or less probability of CAD was predicted for
men aged 52 years or younger and for women aged 66 years
or younger. In the absence of diabetes and PVD, the age
threshold increased to 54 and 69 years for men and women,
respectively (Figure 2, D).DISCUSSION
Although the practice of preoperative CCA in patients
undergoing noncoronary cardiac surgery has become
almost universal, the diagnostic yield of CCA in contempo-
rary practice is unclear. We sought to characterize the
burden of significant CAD among patients undergoing
noncoronary cardiac surgery and to establish simple
bedside models predicting the probability of coexistent
coronary stenosis in the absence of classic disease risk
factors. We detail herein that preoperative CCA reveals
significant coronary stenosis in less than 50% of patients
undergoing noncoronary cardiac surgery and in only one
third of those without angina, previous MI, or PCI. As
such, we constructed risk prediction models and identified
gender-specific age thresholds that successfully detected
patients with a low probability of CAD. These preliminary
findings support the notion that a great number of cardiac
surgical patients are exposed to this invasive and expensive
procedure than is necessary.5,6
An important argument favoring routine CCA before car-
diac surgery is that severe coexistent CAD, left untreated at
noncoronary cardiac surgery, can lead to catastrophic short-
(and long-) term outcomes.1,2 Additionally, the cost and
morbidity associated with the need for postoperative PCI
or repeat sternotomy for CABG is not insignificant. The
addition of concomitant CABG when indicated at index
surgery has thus proved efficacious and safe.1,2,24 The
widespread performance of preoperative CCA has been
supported by current surgical guidelines recommending
angiography before valve surgery for all men aged 35
years or older, premenopausal women aged 35 years or
older with cardiac risk factors, and postmenopausal
women.4 Limited guidance is available for patients under-
going surgical myectomy; however, special concerns may
exist for this population, including the need for concomitant
coronary unroofing to treat myocardial bridging.25,26 These1060 The Journal of Thoracic and Cardiovascular Surand other factors have spawned the liberalized performance
of preoperative CCA before noncoronary cardiac surgery,
which in our population was performed in approximately
90% of patients.
Despite a high sensitivity for the detection of CAD,
guideline specificity has been estimated to be as low as
1% to 3%,5,6 raising questions regarding the diagnostic
yield of this strategy. Evaluating almost 400,000 patients
undergoing elective CCA, Patel et al9 recently reported
that significant coronary stenosis was evident in only one
third of angiograms. Importantly, their analysis excluded
patients undergoing valvular surgery, who account for
most subjects undergoing noncoronary surgery,27 and in
subsets of whom, the risk of underlying CAD may be
increased.10 In our large, contemporary series investigating
the practice of CCA among cardiac surgical candidates, we
found that 45% of the 4711 patients who underwent CCA,
and two thirds of those with angina, previous MI, or PCI,
had significant CAD. This is unsurprising, given that MI
and PCI are markers of previous coronary flow limitation.
Moreover, our findings are consistent with historic reports
estimating that up to one half of patients with valve
pathology and symptoms of angina have underlying
CAD.28 Therefore, our findings support a strategy of CCA
for patients with angina, previous MI, or PCI at the time
of index surgery.
Conversely, significant CAD was only observed in one
third of the 3019 patients free of angina, previous MI, or
PCI. Leveraging this cohort, we successfully constructed
and internally validated 4-variable models with very good
discriminative ability (C-index, 0.69-0.75). Specifically,
the overall model identified that 10% of patients currently
undergoing CCA had a 10% or less probability of CAD.
Subset models (Table 2) were able to identify that approxi-
mately 25% of patients undergoing MVS and more than
50% of those undergoing SM were at low risk of CAD.
We found slightly different results in the patients undergo-
ing AVS—of whom, only 1% had a low probability of
CAD, underlining the increased prevalence of coronary
stenosis in patients undergoing AVS, likely related to the
common risk factors associated with the development of
coronary atherosclerosis and senile calcific aortic valve
disease.11-13 Reassuringly, in all models, only 4% to 6%
of patients classified as having a 10% or less probability
of CAD had significant coronary stenosis, and less than
1% had high-risk disease, supporting the potential utility
of these models.
Our present report examined all patients who had under-
gone AVS, MVS, and SM, thus expanding generalizability
of our findings among the large subpopulations of patients
undergoing preoperative workup for noncoronary cardiac
surgery. Previous prediction algorithms for the detection
of significant CAD were developed in specific surgical
subsets, including patients with degenerative mitral valvegery c November 2013
FIGURE 3. Algorithm for estimating probability of coronary artery disease prior to noncoronary cardiac surgery. MI, Myocardial infarction;
PCI, percutaneous coronary intervention; DM, diabetes mellitus; PVD, peripheral vascular disease; CAD, coronary artery disease; \, female; _, male.
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lengthy calculations required for these logistic regression
models6 have likely limited their bedside utility and
widespread clinical adoption. Lim et al,5 among others,
have attempted to circumvent the need for complex
calculations by developing additive scoring systems to
predict CAD. However, to our knowledge, these models
have not been incorporated into routine patient care. We
are attempting to address these limitations through the
development of a Smartphone application and online
medical calculators to reproduce our risk models in
expanded form.
The present study has established straightforward princi-
ples that are easily applicable at the patient bedside and
provides practitioners with an enhanced ability to adjudi-
cate patient CAD risk beyond the current broad-based and
highly generalized guidelines.4 Specifically, older age,
male gender, diabetes, and PVD were consistently the
most robust predictors of CAD. Given that more than one
half of the patients with diabetes or PVD had significant
CAD, and more than 99% of patients with either of these
risk factors had a greater than 10% predicted probability
of coronary stenosis, our data indicate that patients with
diabetes or PVD are unlikely to be at low risk of coronary
stenosis and, as a general rule, may be best served by
preoperative CCA. In contrast, in those free of diabetes
and PVD at the time of preoperative assessment for index
surgery, we identified gender-specific age thresholds
consistent with a 10% or less probability of CAD, for
whom preoperative CCA could potentially be avoidedThe Journal of Thoracic and Car(Figure 3). The guidance is not exhaustive and cannot
conceivably be expected to completely rule out the
existence of CAD. Our findings are thus not intended to
be taken as substitutes for sound clinical judgment nor the
abandonment of traditional risk stratification schemes.
Future validation of these findings in large multicenter
studies will be important. Furthermore, the question of
‘‘if not CCA, then what?’’ can be justifiably posed.
Computed tomography coronary angiography has emerged
as a promising and efficacious modality by which coronary
obstructions can be identified.31,32 Although not yet
approved for routine evaluation of coronary anatomy
before cardiac surgery, it has been proposed that instead
of replacing CCA, computed tomography coronary
angiography may assume the role of a ‘‘gatekeeper’’:
differentiating between patients free of CAD and those
requiring additional investigation using CCA.33 Additional
studies detailing the cost, efficacy, and safety ratios of
various diagnostic tests are necessary, and are beyond the
scope of the present report.
Importantly, recent trials have demonstrated no advan-
tage for revascularization versus medical therapy in stable
patients with less extensive but ‘‘significant’’ CAD.7,8 It
could thus be proposed that the goal of preoperative
evaluation should perhaps be to identify patients with
left main, multivessel, or critical left anterior descending
artery disease to undergo CABG. Meanwhile, patients
with less severe CAD may be best served by
conservative coronary management at the time of index
surgery.diovascular Surgery c Volume 146, Number 5 1061




Although we investigated a broad range of patients un-
dergoing noncoronary cardiac surgery, the generalizability
of our prediction models remains limited to those
undergoing AVS, MVS, or SM, and model applicability in
other surgical subsets remains to be determined. Thus,
despite internal model validation, future confirmation in
external populations is recommended as a bridge
toward widespread dissemination into clinical practice.
Importantly, we defined a 10% or less risk as being consis-
tent with a low probability of CAD. Although a relatively
subjective threshold that could be challenged as arbitrary,
this decision was guided by previous data18-22 and also by
the consensus judgment of expert cardiologists and
cardiovascular surgeons at our institution. Finally,
although the proposed models do not detect all patients
free of CAD at CCA, they do nevertheless identify a
substantial proportion of patients currently subject to an
invasive and costly procedure who might at some time in
the future be candidates for other less-invasive and more
affordable screening modalities. Thus, when considered in
the context of the current widespread practice of CCA,
our models represent an important step toward optimizing
efficiency of resource allocation while maintaining a high
quality of patient care.
CONCLUSIONS
Almost 90% of subjects undergoing noncoronary cardiac
surgery undergo preoperative CCA. However, in the
absence of angina, previous MI, or PCI, CCA identifies
significant CAD in only one third of patients. Clinical
prediction models can facilitate the identification of
subjects at low risk of CAD, in whom preoperative CCA
might potentially be avoided or substituted prior to
noncoronary cardiac surgery. Ultimately, this strategy
may minimize procedure-related morbidity, decrease cost,
and improve value in health care delivery.
References
1. Lund O, Nielsen T, Pilegaard H, Magnussen K, Knudsen M. The influence of
coronary artery disease and bypass grafting on early and late survival after
valve replacement for aortic stenosis. J Thorac Cardiovasc Surg. 1990;100:
327-37.
2. Mullany CJ, Elveback LR, Frye RL, Pluth JR, Edwards WD, Orszulak TA, et al.
Coronary artery disease and its management: influence on survival in patients
undergoing aortic valve replacement. J Am Coll Cardiol. 1987;10:66-72.
3. Morrison G, Thomas R, Grimmer S, Silverton P, Smith D. Incidence of coronary
artery disease in patients with valvular heart disease. Br Heart J. 1980;44:630-7.
4. Bonow RO, Carabello BA, Chatterjee K, De Leon AC, Faxon DP, FreedMD, et al.
ACC/AHA2006 guidelines for themanagement of patients with valvular heart dis-
ease: a report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for
the Management of Valvular Heart Disease). J Am Coll Cardiol. 2006;48:e1-148.
5. Lim E, Ali ZA, Barlow CW, Jackson CH, Halstead JC, Barlow JB, et al. A simple
model to predict coronary disease in patients undergoing operation for mitral
regurgitation. Ann Thorac Surg. 2003;75:1820-5.
6. Lin SS, Lauer MS, Asher CR, Cosgrove DM, Blackstone E, Thomas JD,
et al. Prediction of coronary artery disease in patients undergoing opera-1062 The Journal of Thoracic and Cardiovascular Surtions for mitral valve degeneration. J Thorac Cardiovasc Surg. 2001;121:
894-901.
7. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al.
Optimal medical therapy with or without PCI for stable coronary disease. N Engl
J Med. 2007;356:1503-16.
8. Frye RL, August P, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, et al.
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
N Engl J Med. 2009;360:2503-15.
9. Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, et al.
Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;
362:886-95.
10. Chandra HR, Goldstein JA, Choudhary N, O’Neill CS, George PB,
Gangasani SR, et al. Adverse outcome in aortic sclerosis is associated with
coronary artery disease and inflammation. J Am Coll Cardiol. 2004;43:169-75.
11. Peltier M, Trojette F, Sarano ME, Grigioni F, Slama MA, Tribouilloy CM.
Relation between cardiovascular risk factors and nonrheumatic severe calcific
aortic stenosis among patients with a three-cuspid aortic valve. Am J Cardiol.
2003;91:97-9.
12. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al.
Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol.
1997;29:630-4.
13. Miller JD, Weiss RM, Heistad DD. Calcific aortic valve stenosis: methods,
models, and mechanisms. Circ Res. 2012;108:1392-412.
14. Society of Thoracic Surgeons Adult Cardiac Surgery Data Specifications.
Available from http://www.sts.org/sts-national-database/database-managers/
adult-cardiac-surgery-database/data-collection. Accessed April 14, 2013.
15. Scanlon PJ, Faxon DP, Audet A, Carabello B, Gregory J, Eagle KA, et al. ACC/
AHA guidelines for coronary angiography: report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines
(Committee on Coronary Angiography). J Am Coll Cardiol. 1999;33:1756-824.
16. Breiman L. Random forests. Machine Learning. 2001;45:5-32.
17. Harrell F. Regression Modeling Strategies: With Applications to Linear Models,
Logistic Regression, and Survival Analysis. Springer Series in Statistics. New
York: Springer; 2001.
18. Hennessy TG, Codd MB, Kane G, McCarthy C, McCann HA, Sugrue DD.
Dobutamine stress echocardiography in the detection of coronary artery disease:
importance of the pretest likelihood of disease. Am Heart J. 1997;134:685-92.
19. Gibbons RJ, Lee KL, Pryor D, Harrell FE, Coleman RE, Cobb FR, et al. The
use of radionuclide angiography in the diagnosis of coronary artery disease—a
logistic regression analysis. Circulation. 1983;68:740-6.
20. Melin JA, Wijns W, Vanbutsele RJ, Robert A, De Coster P, Brasseur LA, et al.
Alternative diagnostic strategies for coronary artery disease in women:
demonstration of the usefulness and efficiency of probability analysis.
Circulation. 1985;71:535-42.
21. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, DuvernoyWFC, Froelicher VF,
et al. ACC/AHA guidelines for exercise testing: a report of the American College
of Cardiology/American Heart Association Task Force on Practice Guidelines
(Committee on Exercise Testing. J Am Coll Cardiol. 1997;30:260-315.
22. Diamond GA, Forrester JS, Hirsch M, Staniloff HM, Vas R, Berman DS, et al.
Application of conditional probability analysis to the clinical diagnosis of
coronary artery disease. J Clin Invest. 1980;65:1210-21.
23. Liaw A, Wiener M. Classification and regression by randomForest. R News.
2002;2:18-22.
24. Czer L, Gray R, Stewart M, De Robertis M, Chaux A, Matloff J. Reduction in
sudden late death by concomitant revascularization with aortic valve
replacement. J Thorac Cardiovasc Surg. 1988;95:390-401.
25. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011
ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomy-
opathy: a report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:
e783-831.
26. Alegria JR, Herrmann J, Holmes DR, Lerman A, Rihal CS. Myocardial bridging.
Eur Heart J. 2005;26:1159-68.
27. Society of Thoracic Surgeons Adult Cardiac Surgery Database Executive
Summary. Available at: http://www.sts.org/sts-national-database/database-
managers/executive-summaries. Accessed February 23, 2013.
28. Exadactylos N, Sugrue DD, Oakley CM. Prevalence of coronary artery disease in
patients with isolated aortic valve stenosis. Br Heart J. 1984;51:121-4.
29. Li SC, Liao XW, Li L, Zhang LM, Xu ZY. Prediction of significant coronary
artery disease in patients undergoing operations for rheumatic mitral valve
disease. Eur J Cardiothorac Surg. 2012;41:82-6.gery c November 2013
Thalji et al Acquired Cardiovascular Disease30. Yan T, Zhang G, Li B, Han L, Zang J, Li L, et al. Prediction of coronary artery
disease in patients undergoing operations for rheumatic aortic valve disease.
Clin Cardiol. 2012;35:707-11.
31. Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, et al.
Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med.
2008;359:2324-36.
32. Mollet NR, Cademartiri F, Van Mieghem CAG, Runza G, McFadden EP, Baks T,
et al. High-resolution spiral computed tomography coronary angiography in
patients referred for diagnostic conventional coronary angiography. Circulation.
2005;112:2318-23.
33. Meijboom WB, Mollet NR, Van Mieghem CAG, Kluin J, Weustink AC,
Pugliese F, et al. Pre-operative computed tomography coronary angiography to
detect significant coronary artery disease in patients referred for cardiac valve
surgery. J Am Coll Cardiol. 2006;48:1658-65.A
C
DDiscussion
Dr Jennifer Sue Lawton (St Louis, Mo). Congratulations on
very nice, very useful work and a very nice presentation. I really
enjoyed your algorithm and the specificity for the different types
of valve pathology. As you know, we do not know the incidence
of significant CAD in the general population, and the study you
quoted from the New England Journal of Medicine by Patel et
al—they did not include valve surgery patients, and they used
different criteria for significant CAD. Your criterion was greater
than 50% stenosis in an epicardial vessel and theirs was 70% or
50% in the left main. They reported on 400,000 patients, approxi-
mately, about one third of whom were asymptomatic but had
disease, but for some reason those patients had undergone cardiac
catheterization. Similarly, in the 2008 updates of the American
Heart Association guidelines, they state that in an asymptomatic
population, the incidence is approximately 4%. So, with that in
mind, looking at your stratification of your study population, 752
patients were ruled out fairly soon if they had not undergone
preoperative catheterization within 6 months of the valve surgery.
Thus, for those patients, I have a question, if you have the data,
about them, because in your report you did mention that a few of
them had had MI or PCI before valve surgery. So, did they not un-
dergo cardiac catheterization before surgery by surgeon preference
or were they young patients with mitral regurgitation? If you have
any data on those patients, because, with that in mind, your estima-
tion of risk and your conclusions might have been underestimated
or overestimated. That is my first question.
Dr Thalji. Thank you very much for your comments, Dr Law-
ton, and for your very insightful question. You raise an important
point. Specifically, that a subset of patients that was excluded,
owing to the absence of preoperative angiography within 6 months
of surgery, did indeed have symptoms of angina, previous PCI, or
previous MI. There are several potential explanations for this.
First, we defined preoperative angiography as being within 6
months of the index surgery. Some patients had undergone preop-
erative angiography that was performed beyond this period; for
instance, within 6 months to 1 year. However, after consultation
with the cardiologists and cardiac surgeons, angiography
performed more than 6 months before surgery were deemed less
likely to be representative of the baseline burden of CAD.
Furthermore, it is also worthwhile noting that about 20% of the
patients who did not undergo conventional invasive angiography
did alternatively undergo computed tomography coronary angiog-
raphy. Most of these patients were those undergoing robotic mitral
valve repair, which, at our institution, is performed by Drs RakeshThe Journal of Thoracic and CarSuri and Harold Burkhart. It is standard practice at our institution
for all patients who undergo robotic cardiac surgery to undergo
computed tomography of the chest, abdomen, and pelvis to assess
for underlying vascular disease, including coronary stenosis. It is,
therefore, possible that these patients who had had MI, PCI, or
angina had been assessed by a computed tomographic angiogram,
which proved to be negative, hence circumventing the need for
conventional angiography.
Dr Lawton. Do you have data for those 752 patients and
whether any of them did undergo concomitant CABG with valve
surgery?
Dr Thalji. That is a good question. Yes, that is correct. Appro-
ximately 25 patients without angiography within 6 months of
surgery did require concomitant CABG. The situation for these
patients, as before, was such that the surgeons believed that
CCA more than 6 months before surgery was sufficient to guide
surgical practice and perform concomitant CABG. This highlights
that our algorithms are simply guides and do not outweigh the
sound clinical judgment of the surgeon.
Dr Lawton.My next question is, sort of as a devil’s advocate, a
number of surgeons are cautious and very conservative; thus,
how would you convince such surgeons to forego cardiac cathete-
rization preoperatively whenwe know additional data can be gained
from the study? It often provides a very nice look at the ascending
aorta and an assessment of left ventricular function. Additional find-
ings could be that that the patient has anomalous coronary anatomy,
such as a double-barrel left main, which could become important,
depending on your cardioplegia strategy. Similarly, if the patient is
right dominant and you plan a very long mitral repair, perhaps that
will not work and requires a replacement and you have only given
retrograde cardioplegia. A number of scenarios are possible, so
how could you convince us we do not need that information?
Dr Thalji. That is a great question, and there are several points
to be made. First, with the pending approval of the Affordable Care
Act, wewill all be called on to scrutinize our actions and assess the
associated costs. Our current investigation is the first step of
multiple studies that are forthcoming to determine whether we
are overusing coronary angiography. However, are we suggesting
that surgeons should abandon angiography altogether? No, we do
not believe this should be the case. What we are suggesting is that
perhaps subsets of patients who specifically are at a low risk of
CAD might be able to either forego invasive angiography or,
alternatively, undergo other less-invasive investigative procedures
to evaluate coronary obstruction. For instance, ventricular function
can potentially be assessed using echocardiography. To delineate
the coronary anatomy, computed tomography coronary angiog-
raphy has become a very popular topic examined in contemporary
studies. I think it is going to take a bit of time before we see a
marked shift in investigative habits; however, we need to start
being self-critical of our clinical practice and to evaluate the effect
it has on patient safety and on healthcare economics.
Dr David C. McGiffin (Birmingham, Ala). Has there been any
change at the clinic since this information, and if so, what do you
do now?
Dr Thalji. To date, what we can say is that there has been a
change in our mind sets. Specifically, we have come to appreciate
that a large divide exists between what we are currently doing and
perhaps what we should be doing. Importantly, validation of our
models in external populations is a critical and necessary stepdiovascular Surgery c Volume 146, Number 5 1063
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clinical practice.
Dr McGiffin. So it has not translated into a change yet?
Dr Thalji. To date, it has not.
Dr Shyam Kolvekar (London, United Kingdom). I enjoyed
your report, and I think your risks come with these problems.
I have 2 small questions. One, did you prefer stress echocardiog-
raphy compared to computed tomography angiography to find
the patients who do not have a high risk and to determine
whether they have any obstructive disease, because it is less inva-
sive? The second question is, did you have any complications
with your angiography patients where they had morbidity or
mortality?
Dr Thalji. Thank you for your questions. Regarding your first
question, you are correct, the published data have shown that stress
echocardiography can be leveraged to obtain valuable information
regarding the coronary disease burden. Although stress echocar-
diography is a less-invasive option, as a general rule of thumb,
clinicians have tended to have a greater peace of mind when
the coronary anatomy has been visualized, such as is the case
with angiography. These are certainly factors that merit consider-
ation when determining which preoperative investigations to
perform.
Regarding your second question, in terms of complications, we
do not have that data available for our population at the moment.1064 The Journal of Thoracic and Cardiovascular SurHowever, we can allude to previously published data detailing
that the rate of major complications at invasive angiography is
approximately 2%. However, as I said, we do not have that data
for our patients specifically.
Dr Rakesh M. Suri (Rochester, Minn). Just to comment on
Nassir’s very thoughtful answer and to respond to 1 of the last
questions. This is a large, retrospective population-based study,
and it was not designed to answer the specific question—if
coronary angiography is avoided, which surrogate tests or which
replacement tests should be ordered instead—that is a topic that
will be addressed in forthcoming investigations. We will be better
prepared to answer that as we move forward.
Dr A. Pieter Kappetein (Rotterdam, The Netherlands). Did
you consider the type of valvular heart disease, whether that
made a difference, whether it was stenotic, aortic valve disease,
or insufficiency?
Dr Thalji. That is a good question. We have not presented
such data. Nevertheless, in a subset analysis, we found that
aortic stenosis was an important variable predictive of underly-
ing significant CAD. Similarly, and as we have documented in
our study, patients undergoing AVS—the vast majority of
whom had aortic stenosis—(1) were more likely to have
coexistent CAD, and (2) were found to have coronary stenosis
at a much younger age compared with those undergoing MVS
or SM.gery c November 2013
TABLE E1. Predictors of significant CAD in patients without angina or previous MI or PCI (n ¼ 3019)
Variable Patients (n)
Univariate Analysis Multivariate Analysisy
OR (95% CI) P value OR (95% CI) P value
Age (per 5 y increment)* — 1.40 (1.35-1.45) <.001 1.40 (1.34-1.47) <.001
Male gender 1910 (63) 1.42 (1.21-1.66) <.001 1.85 (1.54-2.23) <.001
Smoking history 1528 (51) 1.52 (1.30-1.77) <.001 1.30 (1.10-1.55) .003
DM 442 (15) 2.68 (2.18-3.29) <.001 2.01 (1.61-2.53) <.001
Hypertension 1821 (60) 2.09 (1.78-2.46) <.001 1.36 (1.13-1.63) <.001
Hypercholesterolemia 2083 (69) 1.77 (1.49-2.10) <.001 1.49 (1.23-1.80) <.001
Family history CAD 250 (8) 1.68 (1.29-2.18) <.001 1.98 (1.47-2.65) <.001
PVD 158 (5) 4.01 (2.86-5.61) <.001 2.49 (1.72-3.62) <.001
NYHA class III-IV 1395 (46) 1.38 (1.19-1.61) <.001 — —
Obese (BMI 30 kg/m2) 985 (33) 0.94 (0.80-1.11) .47 — —
EF<50% 310 (10) 1.56 (1.25-1.98) <.001 — —
CVA 116 (4) 2.11 (1.46-3.06) <.001 — —
CAD, Coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; OR, odds ratio; CI, confidence interval; DM, diabetes mellitus;
PVD, peripheral vascular disease; NYHA, New York Heart Association; BMI, body mass index; EF, ejection fraction; CVA, cerebrovascular accident. *Age increase by
5-year increments. yOverall model C-index ¼ 0.76.
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